Myoepithelial‐Rich Pleomorphic Adenoma With Novel PLAG1 Inversion on Chromosome 8, and LRP1B, PBRM1 and TCF3 Mutations

Maria F. Gonzalez,Jianming Pei,Yuan Rong,Anjali Seth

DOI: https://doi.org/10.1111/cyt.13459

2024-11-23

Cytopathology

Abstract:Representative images of a fine‐needle aspiration showing a myoepithelial‐rich pleomorphic adenoma with a novel PLAG1 inversion of chromosome 8 and LRP1B, PBRM1 and TCF3 mutations. The diagnosis of pleomorphic adenoma may be challenging due to the predominance of one of the three components. We present the case of a 64‐year‐old male with a remote history of a submandibular gland excision and recent regrowth of his mass in the surgical bed, which was consistent with a myoepithelial‐rich pleomorphic adenoma with a novel inversion of the chromosome 8 and LRP1B, PBRM1, and TCF3 mutations. The cytomorphologic and immunophenotypic pitfalls of this tumor and the differential diagnoses are reviewed in this article. Pleomorphic adenoma (PA) is the most common salivary gland neoplasm worldwide (50%–70%). Most cases of PA are straightforward diagnoses. However, the diagnosis may be challenging due to the morphological diversity of PAs, which in many cases is caused by the predominance of one of the three components or the presence of metaplastic epithelium. We present the case of a 64‐year‐old male with a history of prostate cancer and right submandibular gland excision 16 years ago with an unknown previous diagnosis and recent regrowth of his mass in the surgical bed. The tumour showed a predominant spindle cell morphology, cytokeratin‐positivity, variable expression of myoepithelial markers in the cytology and surgical pathology specimens, and novel inversion of the chromosome 8, and LRP1B, PBRM1 and TCF3 mutations.

pathology,cell biology